Bio-ReCell and AcouSort have signed a Letter of Intent to jointly develop an automated system for the clean-up and isolation of stem cells and immune cells from adipose tissue. This collaboration combines AcouSort’s expertise in acoustofluidic technology with our advanced cell digestion and isolation capabilities.
The partnership follows a successful initial trial at AcouSort’s facility in Lund, where the companies demonstrated the feasibility of using AcouSort’s acoustic separation technology on output from our Revive™ SVF isolation device. The next phase will focus on optimizing and integrating AcouSort’s purification technology to meet our specific needs.
Torsten Freltoft, CEO of AcouSort, commented:
“Collaboration is at the very heart of AcouSort, and it is with great joy we enter into this promising and very exciting partnership."
Dr. Luka Fajs, our CEO, added:
“Advancing technological excellence requires synergy between forward-thinking partners. Our collaboration with AcouSort exemplifies this principle, pushing the boundaries of innovation in cell therapy.”
By combining our strengths, we aim to enhance cell processing efficiency, paving the way for improved manufacturing and development of advanced cell therapies.